Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

NADPH oxidase 4 is expressed in pulmonary artery adventitia and contributes to hypertensive vascular remodeling.

Barman SA, Chen F, Su Y, Dimitropoulou C, Wang Y, Catravas JD, Han W, Orfi L, Szantai-Kis C, Keri G, Szabadkai I, Barabutis N, Rafikova O, Rafikov R, Black SM, Jonigk D, Giannis A, Asmis R, Stepp DW, Ramesh G, Fulton DJ.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1704-15. doi: 10.1161/ATVBAHA.114.303848. Epub 2014 Jun 19.

2.

Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.

Nave AH, Mižíková I, Niess G, Steenbock H, Reichenberger F, Talavera ML, Veit F, Herold S, Mayer K, Vadász I, Weissmann N, Seeger W, Brinckmann J, Morty RE.

Arterioscler Thromb Vasc Biol. 2014 Jul;34(7):1446-58. doi: 10.1161/ATVBAHA.114.303534. Epub 2014 May 15.

3.

Hypoxia induces unique proliferative response in adventitial fibroblasts by activating PDGFβ receptor-JNK1 signalling.

Panzhinskiy E, Zawada WM, Stenmark KR, Das M.

Cardiovasc Res. 2012 Aug 1;95(3):356-65. doi: 10.1093/cvr/cvs194. Epub 2012 Jun 26.

4.

The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.

Green DE, Murphy TC, Kang BY, Kleinhenz JM, Szyndralewiez C, Page P, Sutliff RL, Hart CM.

Am J Respir Cell Mol Biol. 2012 Nov;47(5):718-26. doi: 10.1165/rcmb.2011-0418OC. Epub 2012 Aug 16.

5.

Oxidative stress augments pulmonary hypertension in chronically hypoxic mice overexpressing the oxidized LDL receptor.

Ogura S, Shimosawa T, Mu S, Sonobe T, Kawakami-Mori F, Wang H, Uetake Y, Yoshida K, Yatomi Y, Shirai M, Fujita T.

Am J Physiol Heart Circ Physiol. 2013 Jul 15;305(2):H155-62. doi: 10.1152/ajpheart.00169.2012. Epub 2013 May 17.

6.

Therapeutic efficacy of valproic acid in a combined monocrotaline and chronic hypoxia rat model of severe pulmonary hypertension.

Lan B, Hayama E, Kawaguchi N, Furutani Y, Nakanishi T.

PLoS One. 2015 Jan 28;10(1):e0117211. doi: 10.1371/journal.pone.0117211. eCollection 2015.

7.

Hypoxia-dependent regulation of nonphagocytic NADPH oxidase subunit NOX4 in the pulmonary vasculature.

Mittal M, Roth M, König P, Hofmann S, Dony E, Goyal P, Selbitz AC, Schermuly RT, Ghofrani HA, Kwapiszewska G, Kummer W, Klepetko W, Hoda MA, Fink L, Hänze J, Seeger W, Grimminger F, Schmidt HH, Weissmann N.

Circ Res. 2007 Aug 3;101(3):258-67. Epub 2007 Jun 21.

8.

Oxidative stress contributes to pulmonary hypertension in the transgenic (mRen2)27 rat.

DeMarco VG, Habibi J, Whaley-Connell AT, Schneider RI, Heller RL, Bosanquet JP, Hayden MR, Delcour K, Cooper SA, Andresen BT, Sowers JR, Dellsperger KC.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2659-68. doi: 10.1152/ajpheart.00953.2007. Epub 2008 Apr 18.

9.

[Effect of sesamin on pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary hypertension].

Li XW, Gao YX, Li S, Yang JR.

Zhongguo Zhong Yao Za Zhi. 2015 Apr;40(7):1355-61. Chinese.

PMID:
26281561
10.

Inhibition of phosphodiesterase-1 attenuates cold-induced pulmonary hypertension.

Crosswhite P, Sun Z.

Hypertension. 2013 Mar;61(3):585-92. doi: 10.1161/HYPERTENSIONAHA.111.00676. Epub 2013 Jan 14.

11.

PAR-2 inhibition reverses experimental pulmonary hypertension.

Kwapiszewska G, Markart P, Dahal BK, Kojonazarov B, Marsh LM, Schermuly RT, Taube C, Meinhardt A, Ghofrani HA, Steinhoff M, Seeger W, Preissner KT, Olschewski A, Weissmann N, Wygrecka M.

Circ Res. 2012 Apr 27;110(9):1179-91. doi: 10.1161/CIRCRESAHA.111.257568. Epub 2012 Mar 29.

12.

A novel inhibitor of inducible nitric oxide synthase, ONO-1714, does not ameliorate hypoxia-induced pulmonary hypertension in rats.

Jiang BH, Maruyama J, Yokochi A, Mitani Y, Maruyama K.

Lung. 2007 Sep-Oct;185(5):303-8. Epub 2007 Aug 25.

PMID:
17721804
13.

Caveolin-1 is a negative regulator of NADPH oxidase-derived reactive oxygen species.

Chen F, Barman S, Yu Y, Haigh S, Wang Y, Black SM, Rafikov R, Dou H, Bagi Z, Han W, Su Y, Fulton DJ.

Free Radic Biol Med. 2014 Aug;73:201-13. doi: 10.1016/j.freeradbiomed.2014.04.029. Epub 2014 May 14. Erratum in: Free Radic Biol Med. 2015 Apr;81:184. Black, Stephen M [added]; Rafikov, Ruslan [added].

14.

Leukotriene B4 Activates Pulmonary Artery Adventitial Fibroblasts in Pulmonary Hypertension.

Qian J, Tian W, Jiang X, Tamosiuniene R, Sung YK, Shuffle EM, Tu AB, Valenzuela A, Jiang S, Zamanian RT, Fiorentino DF, Voelkel NF, Peters-Golden M, Stenmark KR, Chung L, Rabinovitch M, Nicolls MR.

Hypertension. 2015 Dec;66(6):1227-39. doi: 10.1161/HYPERTENSIONAHA.115.06370. Epub 2015 Oct 5.

15.

Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species.

Mittal M, Gu XQ, Pak O, Pamenter ME, Haag D, Fuchs DB, Schermuly RT, Ghofrani HA, Brandes RP, Seeger W, Grimminger F, Haddad GG, Weissmann N.

Free Radic Biol Med. 2012 Mar 15;52(6):1033-42. doi: 10.1016/j.freeradbiomed.2011.12.004. Epub 2011 Dec 16.

PMID:
22222468
16.

Critical role for the advanced glycation end-products receptor in pulmonary arterial hypertension etiology.

Meloche J, Courchesne A, Barrier M, Carter S, Bisserier M, Paulin R, Lauzon-Joset JF, Breuils-Bonnet S, Tremblay É, Biardel S, Racine C, Courture C, Bonnet P, Majka SM, Deshaies Y, Picard F, Provencher S, Bonnet S.

J Am Heart Assoc. 2013 Jan 16;2(1):e005157. doi: 10.1161/JAHA.112.005157.

17.

The extracellular signal-regulated kinase is involved in the effects of sildenafil on pulmonary vascular remodeling.

Zeng Z, Li Y, Jiang Z, Wang C, Li B, Jiang W.

Cardiovasc Ther. 2010 Spring;28(1):23-9. doi: 10.1111/j.1755-5922.2009.00115.x.

PMID:
20074256
18.

P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.

Abid S, Houssaïni A, Mouraret N, Marcos E, Amsellem V, Wan F, Dubois-Randé JL, Derumeaux G, Boczkowski J, Motterlini R, Adnot S.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):304-12. doi: 10.1161/ATVBAHA.113.302302. Epub 2013 Dec 12.

19.

Hypoxia downregulates PPARγ via an ERK1/2-NF-κB-Nox4-dependent mechanism in human pulmonary artery smooth muscle cells.

Lu X, Bijli KM, Ramirez A, Murphy TC, Kleinhenz J, Hart CM.

Free Radic Biol Med. 2013 Oct;63:151-60. doi: 10.1016/j.freeradbiomed.2013.05.013. Epub 2013 May 15.

20.

Inhibition of NOX/VPO1 pathway and inflammatory reaction by trimethoxystilbene in prevention of cardiovascular remodeling in hypoxia-induced pulmonary hypertensive rats.

Liu B, Luo XJ, Yang ZB, Zhang JJ, Li TB, Zhang XJ, Ma QL, Zhang GG, Hu CP, Peng J.

J Cardiovasc Pharmacol. 2014 Jun;63(6):567-76. doi: 10.1097/FJC.0000000000000082.

PMID:
24492474

Supplemental Content

Support Center